Concepts (66)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistance, Neoplasm | 2 | 2024 | 307 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 139 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 159 | 0.200 |
Why?
|
| Microsomes, Liver | 4 | 2010 | 75 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 257 | 0.190 |
Why?
|
| Morpholines | 3 | 2010 | 72 | 0.180 |
Why?
|
| Mutation | 1 | 2024 | 1177 | 0.150 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2010 | 38 | 0.140 |
Why?
|
| Sterols | 1 | 2016 | 24 | 0.130 |
Why?
|
| Boronic Acids | 1 | 2016 | 21 | 0.120 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 31 | 0.120 |
Why?
|
| Pyrazoles | 2 | 2024 | 103 | 0.100 |
Why?
|
| Indoles | 2 | 2006 | 187 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2012 | 44 | 0.090 |
Why?
|
| Indomethacin | 1 | 2010 | 25 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2024 | 260 | 0.080 |
Why?
|
| Water Pollutants, Chemical | 1 | 2012 | 171 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 2 | 2004 | 31 | 0.070 |
Why?
|
| Rats | 5 | 2024 | 3735 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2024 | 506 | 0.060 |
Why?
|
| Lactams | 1 | 2024 | 10 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2024 | 1455 | 0.050 |
Why?
|
| Aminopyridines | 1 | 2024 | 26 | 0.050 |
Why?
|
| Piperidines | 1 | 2004 | 83 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2010 | 465 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2676 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2024 | 108 | 0.050 |
Why?
|
| Naphthalenes | 1 | 2002 | 38 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2002 | 61 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2002 | 73 | 0.040 |
Why?
|
| Animals | 6 | 2024 | 16992 | 0.040 |
Why?
|
| Liver | 1 | 2004 | 511 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2016 | 169 | 0.030 |
Why?
|
| Biological Availability | 1 | 2016 | 116 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2016 | 69 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1019 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 2016 | 42 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 121 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 456 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2006 | 280 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2006 | 570 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 6644 | 0.020 |
Why?
|
| Water Pollution, Chemical | 1 | 2012 | 10 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 2012 | 11 | 0.020 |
Why?
|
| New Orleans | 1 | 2012 | 17 | 0.020 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2012 | 21 | 0.020 |
Why?
|
| Fresh Water | 1 | 2012 | 48 | 0.020 |
Why?
|
| Geologic Sediments | 1 | 2012 | 46 | 0.020 |
Why?
|
| Seawater | 1 | 2012 | 54 | 0.020 |
Why?
|
| Mississippi | 1 | 2012 | 129 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 50 | 0.020 |
Why?
|
| Pesticides | 1 | 2012 | 62 | 0.020 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2012 | 46 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 1869 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 107 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2010 | 104 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 241 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 2157 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 611 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 1723 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 140 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 301 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1081 | 0.010 |
Why?
|
| Benzoxazines | 1 | 2002 | 47 | 0.010 |
Why?
|
| Humans | 1 | 2024 | 43102 | 0.010 |
Why?
|
| Female | 1 | 2016 | 24698 | 0.010 |
Why?
|